ArticleAging clinical and experimental research2025
The influence of sarcopenia on health-related quality of life among older patients with gastrointestinal cancer: an assessment using the SarQoL
Article in Aging clinical and experimental research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSarcopenia, characterized by a progressive loss of skeletal muscle mass and function, significantly affects older adults, particularly those with cancer. Although sarcopenia's negative influence on quality of life (QoL) is acknowledged, data on its specific impact among older hospitalized oncology patients remain limited. The aim of the present study was to assess the health-related quality of life in older patients (≥ 65 years) diagnosed with gastrointestinal cancer using the SarQoL
methodsThis cross-sectional study included 97 consecutive patients (≥ 65 years) diagnosed with gastrointestinal cancer, hospitalized at the University Hospital in Krakow between June and September 2023. Participants completed the SarQoL
resultsPatients had moderate impairment in overall QoL (mean SarQoL
conclusionsSarcopenia substantially impairs QoL in older oncology patients, especially regarding leisure and functionality domains. The SarQoL
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.